Buchumschlag

Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer

Immune checkpoint molecule B7-H1 plays a decisive immune regulatory role in different pathologies including cancer, and manipulation of B7-H1 expression became an attractive approach in cancer immunotherapy. Pancreatic cancer (PDAC) is characterized by pronounced immunosuppressive environment and B7...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bazhin, Alexandr V. (VerfasserIn) , Ahn, Katharina von (VerfasserIn) , Fritz, Jasmin (VerfasserIn) , Bunge, Henriette (VerfasserIn) , Maier, Caroline (VerfasserIn) , Isayev, Orkhan (VerfasserIn) , Neff, Florian Matthias (VerfasserIn) , Siveke, Jens T. (VerfasserIn) , Karakhanova, Svetlana (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 01 Mar 2022
In: OncoImmunology
Year: 2022, Jahrgang: 11, Heft: 1, Pages: 1-14
ISSN:2162-402X
DOI:10.1080/2162402X.2022.2043037
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/2162402X.2022.2043037
Volltext
Verfasserangaben:Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Henriette Bunge, Caroline Maier, Orkhan Isayev, Florian Neff, Jens T. Siveke & Svetlana Karakhanova
Beschreibung
Zusammenfassung:Immune checkpoint molecule B7-H1 plays a decisive immune regulatory role in different pathologies including cancer, and manipulation of B7-H1 expression became an attractive approach in cancer immunotherapy. Pancreatic cancer (PDAC) is characterized by pronounced immunosuppressive environment and B7-H1 expression correlates with PDAC prognosis. However, the first attempts to diminish B7-H1 expression in patients were not so successful. This points the complicity of PDAC immunosuppressive network and requires further examinations. We investigated the effect of B7-H1 deficiency in PDAC. Our results clearly show that partial or complete B7-H1 inhibition in vivo let to reduced tumor volume and improved survival of PDAC-bearing mice. This oncological benefit is due to the abrogation of immunosuppression provided by MDSC, macrophages, DC and Treg, which resulted in simultaneous restoration of anti-tumor immune response, namely improved accumulation and functionality of effector-memory CD4 and CD8 T cells. Our results underline the potential of B7-H1 molecule to control immunosuppressive network in PDAC and provide new issues for further clinical investigations.
Beschreibung:Gesehen am 02.05.2022
Beschreibung:Online Resource
ISSN:2162-402X
DOI:10.1080/2162402X.2022.2043037

Ähnliche Einträge